Patent · US Expired

Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin

US6497896B2 · kind B2 · utility

6Cited by
39References
39Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 12, 2001
Grant dateDec 24, 2002
Priority date
Expiry dateFeb 12, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4745
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for administering a camptothecin to a patient comprising: injecting into a patient a pharmaceutical composition comprising an aqueous suspension of microdroplets suitable for intravenous delivery, the microdroplets having a mean diameter between 200 Angstroms and one micron, the microdroplets comprising a substantially water-insoluble, pharmacologically acceptable liquid, a camptothecin dissolved in the water-insoluble, pharmacologically acceptable liquid, and an outer layer comprising a phospholipid. The pharmaceutical composition is particularly well suited for delivering camptothecins, particularly 9-nitro-camptothecin intravenously.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.